Protocol No. 230LE301: A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus a

Project: Research project

Project Details

StatusActive
Effective start/end date3/23/233/22/28

Funding

  • Biogen Idec Incorporated: $13,560.00